Compare Mutual Funds
Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 3Y returns in the bottom 25% of the category. | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 8/9 | 9/9 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 10 Years 11 Months | 13 Years 11 Months | ||
Fund AUM | ₹1565 Cr | ₹9479 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1% | 0.99% | ||
Exit Load | 0.25% | 1% | ||
Benchmark Index | Nifty Pharma TR INR | BSE Healthcare TR INR |
No of Holdings | 39 | 38 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 3 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 99.14% | 97.32% | ||
Debt % | - | - | ||
P/E | 40.58 | 39.2 | ||
P/B | 6.28 | 5.82 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -4.29% | -2.96% | ||
3-Month Return | -0.15% | 0.79% | ||
6-Month Return | 15.2% | 14.88% | ||
1-Year Return | 7.91% | 12.36% | ||
3-Year Return | 18.26% | 17.62% | ||
5-Year Return | 14.01% | 13.51% |
Sharpe | 0.74 | 0.76 | ||
Alpha | -1.52 | -1.58 | ||
Beta | 1 | 0.89 | ||
Standard Deviation | 16.74 | 15.07 | ||
Information Ratio | -0.45 | -0.9 |
Description | Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rajat Srivastava | Sailesh Raj Bhan, Kinjal Desai, Amber Singhania |

